PEDIATRICS Vol. 121 No. 6 June 2008, pp. 1137-1145 (doi:10.1542/peds.2007-1511)
ARTICLE |
Improved Cognitive Development Among Preterm Infants Attributable to Early Supplementation of Human Milk With Docosahexaenoic Acid and Arachidonic Acid
a Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine
b Institute of Psychology, University of Oslo, Oslo, Norway
c Department of Psychology, Lund University, Lund, Sweden
d Department of Pediatrics, Akershus University Hospital and University of Oslo, Akershus Faculty Division, Nordbyhagen, Norway
e Department of Pediatrics Rikshospitalet-Radiumhopitalet Medical Center, Oslo, Norway
f Department of Pediatrics, Vestfold Hospital, Vestfold, Norway
g Department of Pediatrics, Buskerud Hospital, Buskerud, Norway
h Section of Medical Biochemistry, Institute of Medicine, University of Bergen, Bergen, Norway
OBJECTIVE. The objective of our study was to evaluate the effect of supplementation with docosahexaenoic acid and arachidonic acid for human milk-fed preterm infants. The primary end point was cognitive development at 6 months of age.
METHODS. The study was a randomized, double-blind, placebo-controlled study among 141 infants with birth weights of <1500 g. The intervention with 32 mg of docosahexaenoic acid and 31 mg of arachidonic acid per 100 mL of human milk started 1 week after birth and lasted until discharge from the hospital (on average, 9 weeks). Cognitive development was evaluated at 6 months of age by using the Ages and Stages Questionnaire and event-related potentials, a measure of brain correlates related to recognition memory.
RESULTS. There was no difference in adverse events or growth between the 2 groups. At the 6-month follow-up evaluation, the intervention group performed better on the problem-solving subscore, compared with the control group (53.4 vs 49.5 points). There was also a nonsignificant higher total score (221 vs 215 points). The event-related potential data revealed that infants in the intervention group had significantly lower responses after the standard image, compared with the control group (8.6 vs 13.2). There was no difference in responses to novel images.
CONCLUSIONS. Supplementation with docosahexaenoic acid and arachidonic acid for very preterm infants fed human milk in the early neonatal period was associated with better recognition memory and higher problem-solving scores at 6 months.
Key Words: developmental outcomes fatty acids human milk preterm infants very low birth weight
Abbreviations: DHA—docosahexaenoic acid AA—arachidonic acid NC—negative central ERP—event-related potential VLBW—very low birth weight EEG—electroencephalographic EPA—eicosapentaenoic acid
Accepted Sep 28, 2007.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
Q. Yang and T. M. O'Shea Dietary Echium Oil Increases Tissue (n-3) Long-Chain Polyunsaturated Fatty Acids without Elevating Hepatic Lipid Concentrations in Premature Neonatal Rats J. Nutr., July 1, 2009; 139(7): 1353 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Makrides, R. A. Gibson, A. J. McPhee, C. T. Collins, P. G. Davis, L. W. Doyle, K. Simmer, P. B. Colditz, S. Morris, L. G. Smithers, et al. Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid: A Randomized Controlled Trial JAMA, January 14, 2009; 301(2): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G Smithers, R. A Gibson, A. McPhee, and M. Makrides Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||








